ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00016549
Recruitment Status : Completed
First Posted : May 17, 2001
Last Update Posted : July 2, 2017
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)